Puig, N., Agulló, C., Contreras, T., Pérez, J. J., Aires, I., Calasanz, M., . . . Mateos, M. V. (2024). Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.
Citación estilo ChicagoPuig, Noemí|||0000-0001-7535-3861, et al. Single-point and Kinetics of Peripheral Residual Disease By Mass Spectrometry to Predict Outcome in Patients With High-risk Smoldering Multiple Myeloma Included in the GEM-CESAR Trial. 2024.
Cita MLAPuig, Noemí|||0000-0001-7535-3861, et al. Single-point and Kinetics of Peripheral Residual Disease By Mass Spectrometry to Predict Outcome in Patients With High-risk Smoldering Multiple Myeloma Included in the GEM-CESAR Trial. 2024.